VIM and hepatocellular carcinoma: Moreover, it has been reported that knockdown of H19 sensitized HCC cells to sorafenib by downregulating miR-675, thereby preventing EMT in HCC, as illustrated by increased E-cadherin and decreased vimentin expression [48].